Gryphon Therapeutics
Gryphon Therapeutics List of Employees There's an exhaustive list of past and present employees! Get comprehensive information on the number of employees at Gryphon Therapeutics. You can filter them based on skills, years of employment, job, education, department, and prior employment.
Gryphon Therapeutics Salaries. You can even request information on how much does Gryphon Therapeutics pay if you want to. Learn about salaries, pros and cons of working for Gryphon Therapeutics directly from the past employees.
Find People by Employers You can rekindle an old relationship, reconnect with a long-lost friend, former boss, business acquaintance who might be useful in your new line of work. With our employee database, the possibilities are endless. All you have to do is type in a couple of keywords and we'll bring you the exact information you wanted!
23 Gryphon Therapeutics employees in database. Find out everything there's to know about Gryphon Therapeutics employees. We offer you a great deal of unbiased information from the internal database, personal records, and many other details that might be of interest to you.
Gryphon Therapeutics Employees
Employee
Years
Job
Industry
David Tumelty David Tumelty's Gryphon Therapeutics Experience July 2002 - November 2004
Job Director of Chemistry at New England Peptide
Industry Biotechnology
Experience
Bioorganic Chemistry Consulting June 2013 - October 2013
Pfizer January 2012 - May 2013
Pfizer January 2008 - December 2011
CovX July 2006 - December 2007
CovX February 2005 - June 2006
Gryphon Therapeutics July 2002 - November 2004
Affymax, Inc. July 2001 - July 2002
GlaxoSmithKline July 1996 - July 2001
Affymax Research Institute January 1993 - July 1996
Skills
Peptides, Peptide Synthesis, Medicinal Chemistry, Conjugation, Technology Transfer, Pharmaceutical Industry, CMC, CMO management, IND, Biotechnology, Drug Discovery, Oncology, Chemistry, Lead Change, Clinical Development, GMP, In Vitro, Small Molecules, Antibodies, R&D, Parallel Synthesis, Regulatory Submissions, Drug Development
Education
The University of Edinburgh 1989 — 1993
Ph.D., Organic Chemistry
Queen's University Belfast
BSc, Biochemistry
Bioorganic Chemistry Consulting June 2013 - October 2013
Pfizer January 2012 - May 2013
Pfizer January 2008 - December 2011
CovX July 2006 - December 2007
CovX February 2005 - June 2006
Gryphon Therapeutics July 2002 - November 2004
Affymax, Inc. July 2001 - July 2002
GlaxoSmithKline July 1996 - July 2001
Affymax Research Institute January 1993 - July 1996
Skills
Peptides, Peptide Synthesis, Medicinal Chemistry, Conjugation, Technology Transfer, Pharmaceutical Industry, CMC, CMO management, IND, Biotechnology, Drug Discovery, Oncology, Chemistry, Lead Change, Clinical Development, GMP, In Vitro, Small Molecules, Antibodies, R&D, Parallel Synthesis, Regulatory Submissions, Drug Development
Education
The University of Edinburgh 1989 — 1993
Ph.D., Organic Chemistry
Queen's University Belfast
BSc, Biochemistry
Susan Whitehead Susan Whitehead's Gryphon Therapeutics Experience 2003 - 2004
Job Project Management Consultant
Industry Pharmaceuticals
Experience
Asante Group Consulting Corporation November 2010 - Present
BN ImmunoTherapeutics November 2012 - December 2014
BiPar Sciences (A Sanofi-Aventis Company) March 2009 - June 2011
All Phaze Solutions, Inc September 2008 - March 2010
Conor MedSystems, a Johnson & Johnson Co. August 2006 - September 2008
ALZA Corporation, a Johnson & Johnson Co. April 2004 - August 2006
Gryphon Therapeutics 2003 - 2004
Sunesis Pharmaceuticals 2001 - 2003
Merck & Co, Inc June 1998 - August 1998
Pharmacia & Upjohn June 1997 - August 1997
Skills
Medical Devices, Biotechnology, Clinical Trials, R&D, Clinical Development, Product Development, Clinical Research, Drug Development, FDA, Commercialization, Pharmaceutical Industry, Validation, Lifesciences, GMP, Technology Transfer, Quality System, CAPA, Regulatory Affairs, Design Control, Oncology, Sop, CRO, Chemistry, Cross-functional Team..., Drug Delivery, Drug Discovery, GCP, GLP, GxP, IND, Immunology, Organic Chemistry, Program Management, Project Management, Project Portfolio..., Strategy, Vaccines, V, Process Simulation, Start-ups, Quality Assurance, Change Control, HPLC, Clinical Data Management, Analytical Chemistry
Education
Michigan State University 1996 — 1999
BS
Continuing Education
Asante Group Consulting Corporation November 2010 - Present
BN ImmunoTherapeutics November 2012 - December 2014
BiPar Sciences (A Sanofi-Aventis Company) March 2009 - June 2011
All Phaze Solutions, Inc September 2008 - March 2010
Conor MedSystems, a Johnson & Johnson Co. August 2006 - September 2008
ALZA Corporation, a Johnson & Johnson Co. April 2004 - August 2006
Gryphon Therapeutics 2003 - 2004
Sunesis Pharmaceuticals 2001 - 2003
Merck & Co, Inc June 1998 - August 1998
Pharmacia & Upjohn June 1997 - August 1997
Skills
Medical Devices, Biotechnology, Clinical Trials, R&D, Clinical Development, Product Development, Clinical Research, Drug Development, FDA, Commercialization, Pharmaceutical Industry, Validation, Lifesciences, GMP, Technology Transfer, Quality System, CAPA, Regulatory Affairs, Design Control, Oncology, Sop, CRO, Chemistry, Cross-functional Team..., Drug Delivery, Drug Discovery, GCP, GLP, GxP, IND, Immunology, Organic Chemistry, Program Management, Project Management, Project Portfolio..., Strategy, Vaccines, V, Process Simulation, Start-ups, Quality Assurance, Change Control, HPLC, Clinical Data Management, Analytical Chemistry
Education
Michigan State University 1996 — 1999
BS
Continuing Education
Darren Thompson Darren Thompson's Gryphon Therapeutics Experience February 2003 - February 2004
Job Principal Consultant APEX Think
Industry Biotechnology
Experience
Scimitar Inc. January 2015 - Present
APEX Think Consulting November 2012 - Present
Assay Depot February 2013 - November 2014
Merck Millipore March 2011 - November 2012
Life Technologies March 2010 - December 2010
Life Technologies October 2009 - March 2010
HX Diagnostics October 2008 - October 2009
PRTM June 2006 - October 2008
Quest Diagnostics February 2004 - June 2006
Gryphon Therapeutics February 2003 - February 2004
Skills
Product Development, Strategy, Medical Devices, Business Strategy, Product Launch, Management, Project Portfolio..., Leadership, Six Sigma, Project Management, Manufacturing, Pharmaceutical Industry, Change Management, Training, R&D, Supply Chain, Cross-functional Team..., Biotechnology, Product Management, Business Development, Lifesciences, Start-ups, Commercialization, Innovation Management, Life Sciences
Education
University of Warwick - Warwick Business School 1997 — 2001
MBA
University of Wales, Swansea 1992 — 1995
Molecular Biology, BSc.
Scimitar Inc. January 2015 - Present
APEX Think Consulting November 2012 - Present
Assay Depot February 2013 - November 2014
Merck Millipore March 2011 - November 2012
Life Technologies March 2010 - December 2010
Life Technologies October 2009 - March 2010
HX Diagnostics October 2008 - October 2009
PRTM June 2006 - October 2008
Quest Diagnostics February 2004 - June 2006
Gryphon Therapeutics February 2003 - February 2004
Skills
Product Development, Strategy, Medical Devices, Business Strategy, Product Launch, Management, Project Portfolio..., Leadership, Six Sigma, Project Management, Manufacturing, Pharmaceutical Industry, Change Management, Training, R&D, Supply Chain, Cross-functional Team..., Biotechnology, Product Management, Business Development, Lifesciences, Start-ups, Commercialization, Innovation Management, Life Sciences
Education
University of Warwick - Warwick Business School 1997 — 2001
MBA
University of Wales, Swansea 1992 — 1995
Molecular Biology, BSc.
David Meininger's Gryphon Therapeutics Experience September 2002 - May 2003
Job Senior Vice President Business Development at OncoSec Medical Incorporated
Industry Pharmaceuticals
Experience
OncoSec Medical Incorporated September 2015 - Present
Merck October 2013 - September 2015
Merck July 2012 - October 2013
Merck April 2011 - July 2012
Boehringer Ingelheim August 2010 - January 2011
Amgen, Inc. March 2007 - June 2010
Amgen, Inc. April 2005 - March 2007
Tularik, Inc. May 2003 - March 2005
Gryphon Therapeutics September 2002 - May 2003
Triad Therapeutics, Inc. September 1999 - September 2002
Skills
Biotechnology, Drug Discovery, Life Sciences, Biochemistry, Protein Engineering, Protein Purification, Protein Chemistry, Structural Biology, Tissue Culture, Molecular Cloning, Mass Spectrometry, Peptide Synthesis, Organic Synthesis, High Throughput..., Financial Modeling, Budget Management, Cell Based Assays, Enzyme Assays, Antibody Engineering, Antibodies, Assay Development, Budgets, Cancer, Cell, Chromatography, Immunology, Inflammation, Lifesciences, Monoclonal Antibodies, Protein Expression, Biopharmaceuticals
Education
University of Washington, Michael G. Foster School of Business 2007 — 2008
M.B.A., Technology Management
University of California, San Diego 1992 — 1997
Ph.D., Chemistry
University of Florida 1989 — 1991
B.S., Chemistry
OncoSec Medical Incorporated September 2015 - Present
Merck October 2013 - September 2015
Merck July 2012 - October 2013
Merck April 2011 - July 2012
Boehringer Ingelheim August 2010 - January 2011
Amgen, Inc. March 2007 - June 2010
Amgen, Inc. April 2005 - March 2007
Tularik, Inc. May 2003 - March 2005
Gryphon Therapeutics September 2002 - May 2003
Triad Therapeutics, Inc. September 1999 - September 2002
Skills
Biotechnology, Drug Discovery, Life Sciences, Biochemistry, Protein Engineering, Protein Purification, Protein Chemistry, Structural Biology, Tissue Culture, Molecular Cloning, Mass Spectrometry, Peptide Synthesis, Organic Synthesis, High Throughput..., Financial Modeling, Budget Management, Cell Based Assays, Enzyme Assays, Antibody Engineering, Antibodies, Assay Development, Budgets, Cancer, Cell, Chromatography, Immunology, Inflammation, Lifesciences, Monoclonal Antibodies, Protein Expression, Biopharmaceuticals
Education
University of Washington, Michael G. Foster School of Business 2007 — 2008
M.B.A., Technology Management
University of California, San Diego 1992 — 1997
Ph.D., Chemistry
University of Florida 1989 — 1991
B.S., Chemistry
Janette Tack Janette Tack's Gryphon Therapeutics Experience January 2001 - July 2004
Job Technical Manager Supplier Quality at Genentech
Industry Biotechnology
Experience
Genentech January 2015 - Present
Genentech June 2007 - Present
Gryphon Therapeutics January 2001 - July 2004
Skills
Analytical Chemistry, HPLC, UV-Vis, Mass Spectrometry, Chemistry, Spectroscopy, cGMP, Chromatography, LC-MS, Protein Purification, UV/Vis, GMP, Nanotechnology, R&D, GxP, Validation, Biotechnology, Capillary..., GLP, Purification, Drug Development, Assay Development, Organic Chemistry, LIMS, Biochemistry, Biopharmaceuticals, Drug Discovery, Protein Chemistry
Education
Monash University
MS, Organic Chemistry
Genentech January 2015 - Present
Genentech June 2007 - Present
Gryphon Therapeutics January 2001 - July 2004
Skills
Analytical Chemistry, HPLC, UV-Vis, Mass Spectrometry, Chemistry, Spectroscopy, cGMP, Chromatography, LC-MS, Protein Purification, UV/Vis, GMP, Nanotechnology, R&D, GxP, Validation, Biotechnology, Capillary..., GLP, Purification, Drug Development, Assay Development, Organic Chemistry, LIMS, Biochemistry, Biopharmaceuticals, Drug Discovery, Protein Chemistry
Education
Monash University
MS, Organic Chemistry
Janice Schindler-Horvat Janice Schindler-Horvat's Gryphon Therapeutics Experience 2001 - 2003
Job Director, Marketing at SRI International Biosciences
Industry Pharmaceuticals
Experience
SRI (Stanford Research Institute) 1981 - Present
Gryphon Therapeutics 2001 - 2003
Skills
Proposal Writing, Lifesciences, Drug Development, R&D, Drug Discovery, Technical Writing, Immunology, Strategic Planning, Commercialization, Pharmaceutical Industry, Biotechnology, Infectious Diseases, FDA, Oncology, Vaccines, Genomics, Clinical Development, Molecular Biology, CRO, Biochemistry
Education
The Ohio State University 1977 — 1979
Kent State University 1975 — 1977
Zoology
SRI (Stanford Research Institute) 1981 - Present
Gryphon Therapeutics 2001 - 2003
Skills
Proposal Writing, Lifesciences, Drug Development, R&D, Drug Discovery, Technical Writing, Immunology, Strategic Planning, Commercialization, Pharmaceutical Industry, Biotechnology, Infectious Diseases, FDA, Oncology, Vaccines, Genomics, Clinical Development, Molecular Biology, CRO, Biochemistry
Education
The Ohio State University 1977 — 1979
Kent State University 1975 — 1977
Zoology
Vasilis Voudouris Vasilis Voudouris's Gryphon Therapeutics Experience 2004 - 2004
Job Principal and Founder at Vereniki Solutions
Industry Biotechnology
Experience
Vereniki Solutions June 2007 - Present
Ampac Fine Chemicals 2008 - 2010
Nektar Therapeutics 2006 - 2007
Genentech 2004 - 2006
Gryphon Therapeutics 2004 - 2004
Bayer 1996 - 2004
Dow AgroSciences 1993 - 1995
Skills
Process Development, Life Sciences, Medical Devices, Biotechnology, Manufacturing, FDA, R&D, Lean Manufacturing, Pharmaceuticals, Diagnostics, Healthcare, Consumer Products, Disposables, Six Sigma, Supply Chain, Product Development, Pharmaceutical Industry, Lifesciences, Process Simulation, Product Management
Education
Imperial College London 1995 — 1996
MBA, Management
Carnegie Mellon University 1989 — 1993
Ph.D., Chemical Engineering, 3.9 / 4.0
Aristoteleion Panepistimion Thessalonikis 1984 — 1989
Diploma in Engineering ( ~ MEng), Chemical Engineering, 9.0 / 10.00
Vereniki Solutions June 2007 - Present
Ampac Fine Chemicals 2008 - 2010
Nektar Therapeutics 2006 - 2007
Genentech 2004 - 2006
Gryphon Therapeutics 2004 - 2004
Bayer 1996 - 2004
Dow AgroSciences 1993 - 1995
Skills
Process Development, Life Sciences, Medical Devices, Biotechnology, Manufacturing, FDA, R&D, Lean Manufacturing, Pharmaceuticals, Diagnostics, Healthcare, Consumer Products, Disposables, Six Sigma, Supply Chain, Product Development, Pharmaceutical Industry, Lifesciences, Process Simulation, Product Management
Education
Imperial College London 1995 — 1996
MBA, Management
Carnegie Mellon University 1989 — 1993
Ph.D., Chemical Engineering, 3.9 / 4.0
Aristoteleion Panepistimion Thessalonikis 1984 — 1989
Diploma in Engineering ( ~ MEng), Chemical Engineering, 9.0 / 10.00
Alexander R. Lussow, PhD Alexander R. Lussow, PhD's Gryphon Therapeutics Experience March 2001 - November 2004
Job Senior Vice President, Business Development and Commercial Operations at QLT Inc.
Industry Biotechnology
Experience
QLT Inc. July 2006 - Present
Broad Reach: The fastest way to sale November 2005 - July 2006
Gryphon Therapeutics March 2001 - November 2004
SangStat March 1995 - March 2001
Skills
Technology Transfer, Biotechnology, Lifesciences, Drug Development, Clinical Development, Pharmaceutical Industry, Commercialization, Biopharmaceuticals, Drug Discovery, Oncology, Cancer, Clinical Trials, Immunology, Infectious Diseases, Strategic Alliances, Regulatory Affairs, FDA, GCP, Medical Devices, Medical Affairs, R&D, Pharmacology, Vaccines, CRO, Patents, IND, Licensing, Strategy, Corporate Development, Business Development, Entrepreneurship, Life Sciences, Strategic Negotiations
Education
Ludwig Institute for Cancer Research 1991 — 1994
Post doc, Immunology
University of Geneva 1987 — 1992
PhD, Immunology
McGill University 1980 — 1984
BSc, Microbiology and Immunology
QLT Inc. July 2006 - Present
Broad Reach: The fastest way to sale November 2005 - July 2006
Gryphon Therapeutics March 2001 - November 2004
SangStat March 1995 - March 2001
Skills
Technology Transfer, Biotechnology, Lifesciences, Drug Development, Clinical Development, Pharmaceutical Industry, Commercialization, Biopharmaceuticals, Drug Discovery, Oncology, Cancer, Clinical Trials, Immunology, Infectious Diseases, Strategic Alliances, Regulatory Affairs, FDA, GCP, Medical Devices, Medical Affairs, R&D, Pharmacology, Vaccines, CRO, Patents, IND, Licensing, Strategy, Corporate Development, Business Development, Entrepreneurship, Life Sciences, Strategic Negotiations
Education
Ludwig Institute for Cancer Research 1991 — 1994
Post doc, Immunology
University of Geneva 1987 — 1992
PhD, Immunology
McGill University 1980 — 1984
BSc, Microbiology and Immunology
Don Low's Gryphon Therapeutics Experience 2002 - 2005
Job Principal Site Manager at Genentech
Industry Biotechnology
Experience
Genentech September 2010 - Present
Baxter BioScience 2009 - September 2010
Ethos Pharmaceuticals April 2008 - September 2008
PDL Biopharma May 2006 - April 2008
Gryphon Therapeutics 2002 - 2005
Gryphon Therapeutics 1999 - 2002
Gryphon Sciences 1997 - 1999
Skills
Contract Negotiation, Chemistry, Protein Chemistry, Drug Discovery, Technology Transfer, Biotechnology, Validation, Manufacturing, GMP, Purification, Pharmaceutical Industry, HPLC, Clinical Development, Protein Purification, IND, Assay Development, Monoclonal Antibodies, Biochemistry, Formulation, Drug Development, Mass Spectrometry
Education
Caltech 1990 — 1997
PhD, Chemistry
UC Berkeley 1986 — 1990
BA, Chemistry
Genentech September 2010 - Present
Baxter BioScience 2009 - September 2010
Ethos Pharmaceuticals April 2008 - September 2008
PDL Biopharma May 2006 - April 2008
Gryphon Therapeutics 2002 - 2005
Gryphon Therapeutics 1999 - 2002
Gryphon Sciences 1997 - 1999
Skills
Contract Negotiation, Chemistry, Protein Chemistry, Drug Discovery, Technology Transfer, Biotechnology, Validation, Manufacturing, GMP, Purification, Pharmaceutical Industry, HPLC, Clinical Development, Protein Purification, IND, Assay Development, Monoclonal Antibodies, Biochemistry, Formulation, Drug Development, Mass Spectrometry
Education
Caltech 1990 — 1997
PhD, Chemistry
UC Berkeley 1986 — 1990
BA, Chemistry
Myriam DeTrinidad's Gryphon Therapeutics Experience 2002 - 2003
Job Quality Assurance
Industry Biotechnology
Experience
Gilead Sciences July 2014 - Present
Novartis January 2014 - July 2014
Astellas Pharma September 2009 - August 2013
Maxygen August 2003 - August 2009
Gryphon Therapeutics 2002 - 2003
Corixa 2001 - 2002
Applied Biosystems 2001 - 2001
Genentech 2000 - 2000
Skills
Protein Purification, Biotechnology, Protein Chemistry, ELISA, Cell Culture, Protein Expression, Purification, SDS-PAGE, Biopharmaceuticals, GMP, Sop, IND, Technology Transfer, Antibodies, Assay Development, GLP, Monoclonal Antibodies, Chromatography, Lifesciences, Drug Discovery, HPLC
Education
University of California, Santa Cruz 2006 — 2008
Certificate, Clinical Trial Design and Management
University of California, San Diego
Bachelor of Science (B.S.), Biochemistry
Gilead Sciences July 2014 - Present
Novartis January 2014 - July 2014
Astellas Pharma September 2009 - August 2013
Maxygen August 2003 - August 2009
Gryphon Therapeutics 2002 - 2003
Corixa 2001 - 2002
Applied Biosystems 2001 - 2001
Genentech 2000 - 2000
Skills
Protein Purification, Biotechnology, Protein Chemistry, ELISA, Cell Culture, Protein Expression, Purification, SDS-PAGE, Biopharmaceuticals, GMP, Sop, IND, Technology Transfer, Antibodies, Assay Development, GLP, Monoclonal Antibodies, Chromatography, Lifesciences, Drug Discovery, HPLC
Education
University of California, Santa Cruz 2006 — 2008
Certificate, Clinical Trial Design and Management
University of California, San Diego
Bachelor of Science (B.S.), Biochemistry
Yvonne Chinn's Gryphon Therapeutics Experience March 2003 - November 2004
Job Research Associate
Industry Biotechnology
Experience
Genentech January 2005 - Present
Gryphon Therapeutics March 2003 - November 2004
Education
University of California, Berkeley
Bachelor of Arts (B.A.), Cell/Cellular and Molecular Biology
Genentech January 2005 - Present
Gryphon Therapeutics March 2003 - November 2004
Education
University of California, Berkeley
Bachelor of Arts (B.A.), Cell/Cellular and Molecular Biology
Vincent Gueriguian's Gryphon Therapeutics Experience 1998 - 2004
Job Global Project Manager at Genentech
Industry Biotechnology
Experience
Genentech June 2014 - Present
Abbott Vascular November 2009 - June 2014
Abbott Vascular February 2005 - November 2009
Gryphon Therapeutics 1998 - 2004
Skills
Medical Devices, Design Control, FDA, R&D, GMP, Biotechnology, Catheters, Lifesciences, Biomedical Engineering, Biomaterials, Vascular, Validation
Education
University of California, Berkeley 1993 — 1998
Bachelor of Science (B.S.), Chemical Engineering
Genentech June 2014 - Present
Abbott Vascular November 2009 - June 2014
Abbott Vascular February 2005 - November 2009
Gryphon Therapeutics 1998 - 2004
Skills
Medical Devices, Design Control, FDA, R&D, GMP, Biotechnology, Catheters, Lifesciences, Biomedical Engineering, Biomaterials, Vascular, Validation
Education
University of California, Berkeley 1993 — 1998
Bachelor of Science (B.S.), Chemical Engineering
Alexander Kravchuk's Gryphon Therapeutics Experience January 2004 - June 2005
Job Senior Scientist at University of Vienna
Industry Biotechnology
Experience
University of Vienna July 2011 - Present
Politecnico di Milano April 2008 - July 2011
Amylin Pharmaceuticals August 2005 - October 2007
Gryphon Therapeutics January 2004 - June 2005
Institute of Biochemistry and Physiology of Microorganisms September 1989 - June 1993
Skills
HPLC, LC-MS, NMR, MALDI-TOF, FPLC, Protein Chemistry, Enzyme Kinetics, Peptides, Protein Expression, Chromatography, Mass Spectrometry, Biochemistry, Peptide Synthesis, NMR spectroscopy, Assay Development, Biotechnology, Protein Engineering
Education
Stanford University 1999 — 2004
Postdoc, Enzymology of ribozymes
The Ohio State University 1993 — 1999
PhD, Enzymology, protein chemistry, NMR
Lomonosov Moscow State University (MSU) 1984 — 1989
M.Sc., Chemistry
University of Vienna July 2011 - Present
Politecnico di Milano April 2008 - July 2011
Amylin Pharmaceuticals August 2005 - October 2007
Gryphon Therapeutics January 2004 - June 2005
Institute of Biochemistry and Physiology of Microorganisms September 1989 - June 1993
Skills
HPLC, LC-MS, NMR, MALDI-TOF, FPLC, Protein Chemistry, Enzyme Kinetics, Peptides, Protein Expression, Chromatography, Mass Spectrometry, Biochemistry, Peptide Synthesis, NMR spectroscopy, Assay Development, Biotechnology, Protein Engineering
Education
Stanford University 1999 — 2004
Postdoc, Enzymology of ribozymes
The Ohio State University 1993 — 1999
PhD, Enzymology, protein chemistry, NMR
Lomonosov Moscow State University (MSU) 1984 — 1989
M.Sc., Chemistry
Shiah-yun Chen's Gryphon Therapeutics Experience 1999 - 2004
Job Director, Analytical Development, CMC at Anacor Pharmaceuticals
Industry Biotechnology
Experience
Anacor Pharmaceuticals March 2012 - Present
Anacor Pharmaceuticals October 2011 - March 2012
Relypsa July 2010 - June 2011
Relypsa October 2007 - July 2010
Ilypsa May 2005 - October 2007
Gryphon Therapeutics 1999 - 2004
Skills
CMC, Technology Transfer, Formulation, Biotechnology, Organic Chemistry, Analytical Chemistry, GC-MS, Polymer Chemistry, ICP, Pharmaceutical Industry, Drug Discovery
Education
University of California, Berkeley 1993 — 1999
Doctor of Philosophy (Ph.D.), Chemistry/Molucular Cell Biology
Anacor Pharmaceuticals March 2012 - Present
Anacor Pharmaceuticals October 2011 - March 2012
Relypsa July 2010 - June 2011
Relypsa October 2007 - July 2010
Ilypsa May 2005 - October 2007
Gryphon Therapeutics 1999 - 2004
Skills
CMC, Technology Transfer, Formulation, Biotechnology, Organic Chemistry, Analytical Chemistry, GC-MS, Polymer Chemistry, ICP, Pharmaceutical Industry, Drug Discovery
Education
University of California, Berkeley 1993 — 1999
Doctor of Philosophy (Ph.D.), Chemistry/Molucular Cell Biology
Carole Parfett's Gryphon Therapeutics Experience 1999 - 1999
Job Independent Human Resources Professional
Industry Human Resources
Experience
ANTs Software, Inc 2000 - 2007
ANT's Software (ANTS.BB) 2000 - 2007
Gryphon Therapeutics 1999 - 1999
Education
San Francisco State University 1989 — 1993
ANTs Software, Inc 2000 - 2007
ANT's Software (ANTS.BB) 2000 - 2007
Gryphon Therapeutics 1999 - 1999
Education
San Francisco State University 1989 — 1993
Glenn Shimizu's Gryphon Therapeutics Experience 2002 - 2003
Job Quality Engineer at Genentech
Industry Biotechnology
Experience
Genentech July 2003 - Present
Gryphon Therapeutics 2002 - 2003
Gryphon Sciences 2001 - 2002
Peninsula Laboratories, Inc. 1997 - 2001
Peninsula Laboratories, Inc. 1987 - 1997
Skills
FDA, GMP, Purification, Quality System, Peptide Synthesis, CAPA, Quality Assurance, Quality Control, Continuous Improvement
Education
University of California, San Diego 1980 — 1985
Carlmont High School
Genentech July 2003 - Present
Gryphon Therapeutics 2002 - 2003
Gryphon Sciences 2001 - 2002
Peninsula Laboratories, Inc. 1997 - 2001
Peninsula Laboratories, Inc. 1987 - 1997
Skills
FDA, GMP, Purification, Quality System, Peptide Synthesis, CAPA, Quality Assurance, Quality Control, Continuous Improvement
Education
University of California, San Diego 1980 — 1985
Carlmont High School
Kimi Mack's Gryphon Therapeutics Experience July 2002 - November 2003
Job Editor
Industry Writing and Editing
Experience
Annual Reviews November 2008 - September 2010
Stanford University September 2008 - October 2008
Dionex Corporation 2004 - 2006
Gryphon Therapeutics July 2002 - November 2003
Whitehats Inc. January 2000 - July 2001
Education
University of California, Berkeley 2000 — 2001
B.A., Mass Communications
Annual Reviews November 2008 - September 2010
Stanford University September 2008 - October 2008
Dionex Corporation 2004 - 2006
Gryphon Therapeutics July 2002 - November 2003
Whitehats Inc. January 2000 - July 2001
Education
University of California, Berkeley 2000 — 2001
B.A., Mass Communications
James Bradburne, Ph.D.'s Gryphon Therapeutics Experience July 2000 - June 2005
Job Intellectual Property Consultant
Industry Biotechnology
Experience
Clear Path IP, LLC July 2005 - Present
Gryphon Therapeutics July 2000 - June 2005
Gryphon Sciences July 1999 - July 2000
Cooley Godward June 1997 - June 1999
Rae-Venter and Associates September 1995 - May 1997
Weil Gotshal and Manges April 1992 - August 1995
Skills
Licensing, Patent Prosecution, Pharmaceutical Industry, Patents, Biochemistry, Patent Litigation, Biotechnology, Due Diligence, R&D, Competitive Analysis, Strategy, Management, Technology Transfer, Molecular Biology, Business Development
Education
Georgia Institute of Technology 1989 — 1992
PhD, Molecular Biology & Biochemistry
Georgia Institute of Technology 1987 — 1989
MS, Plant Physiology
Virginia Polytechnic Institute and State University 1981 — 1986
BS, Biochemistry
Clear Path IP, LLC July 2005 - Present
Gryphon Therapeutics July 2000 - June 2005
Gryphon Sciences July 1999 - July 2000
Cooley Godward June 1997 - June 1999
Rae-Venter and Associates September 1995 - May 1997
Weil Gotshal and Manges April 1992 - August 1995
Skills
Licensing, Patent Prosecution, Pharmaceutical Industry, Patents, Biochemistry, Patent Litigation, Biotechnology, Due Diligence, R&D, Competitive Analysis, Strategy, Management, Technology Transfer, Molecular Biology, Business Development
Education
Georgia Institute of Technology 1989 — 1992
PhD, Molecular Biology & Biochemistry
Georgia Institute of Technology 1987 — 1989
MS, Plant Physiology
Virginia Polytechnic Institute and State University 1981 — 1986
BS, Biochemistry
Ada Hsiao-Chia Kung's Gryphon Therapeutics Experience 2000 - 2003
Job CEO, Chief Executive Officer at Meridigen Biotech
Industry Biotechnology
Experience
Meridigen Biotech September 2012 - Present
TaiGen Biotechnology May 2010 - January 2012
Expedient-Solutions International (consulting firm) May 2008 - May 2010
Bridge Laboratories August 2004 - May 2008
Gryphon Therapeutics 2000 - 2003
Skills
Biotechnology, Immunology, GLP, Drug Development, Clinical Development, FDA
Education
The Ohio State University
Ph.D., Physiology
Meridigen Biotech September 2012 - Present
TaiGen Biotechnology May 2010 - January 2012
Expedient-Solutions International (consulting firm) May 2008 - May 2010
Bridge Laboratories August 2004 - May 2008
Gryphon Therapeutics 2000 - 2003
Skills
Biotechnology, Immunology, GLP, Drug Development, Clinical Development, FDA
Education
The Ohio State University
Ph.D., Physiology
Maia Carnevali's Gryphon Therapeutics Experience March 2002 - July 2004
Job Process Development Chemist at PolyPeptide Group
Industry Biotechnology
Experience
PolyPeptide Group April 2015 - Present
American Peptide Company August 2014 - April 2015
Aridis Pharmaceutical January 2012 - July 2014
University of California at San Diego September 2004 - June 2011
Gryphon Therapeutics March 2002 - July 2004
Gryphon Sciences September 1999 - March 2002
Skills
Medicinal Chemistry, Characterization, UV/Vis, Fluorescence..., Peptide Synthesis, Organic Chemistry, Organic Synthesis, HPLC, Analytical Chemistry, NMR spectroscopy, LC-MS, Drug Discovery, Biotechnology, Purification, Chromatography, Atomic Absorption, Analytical Methods..., Assay Development, Ion Chromatography, synthesis process..., cGMP manufacturing
Education
University of California, San Diego 2004 — 2011
Ph.D., Chemistry
University of California, Santa Cruz 1997 — 1999
Bachelor of Science, Biochemistry and Molecular Biology
PolyPeptide Group April 2015 - Present
American Peptide Company August 2014 - April 2015
Aridis Pharmaceutical January 2012 - July 2014
University of California at San Diego September 2004 - June 2011
Gryphon Therapeutics March 2002 - July 2004
Gryphon Sciences September 1999 - March 2002
Skills
Medicinal Chemistry, Characterization, UV/Vis, Fluorescence..., Peptide Synthesis, Organic Chemistry, Organic Synthesis, HPLC, Analytical Chemistry, NMR spectroscopy, LC-MS, Drug Discovery, Biotechnology, Purification, Chromatography, Atomic Absorption, Analytical Methods..., Assay Development, Ion Chromatography, synthesis process..., cGMP manufacturing
Education
University of California, San Diego 2004 — 2011
Ph.D., Chemistry
University of California, Santa Cruz 1997 — 1999
Bachelor of Science, Biochemistry and Molecular Biology
Haiyan Lu's Gryphon Therapeutics Experience June 2002 - November 2004
Job
Industry Pharmaceuticals
Experience
Enzon Pharmaceuticals August 2005 - Present
Bristol-Myers Squibb February 2005 - August 2005
Gryphon Therapeutics June 2002 - November 2004
BACHEM-Peninsula Laboratories Inc. July 2001 - June 2002
San Francisco State University September 1998 - July 2001
Skills
bioanalytical method..., protein characterization, PK/PD method..., HPLC/UPLC, LC/MS/MS
Education
Tsinghua University 1995 — 1998
PhD, Chemistry
Central China Normal University
MS, Chemistry
Central China Normal University
BS, Chemistry
Enzon Pharmaceuticals August 2005 - Present
Bristol-Myers Squibb February 2005 - August 2005
Gryphon Therapeutics June 2002 - November 2004
BACHEM-Peninsula Laboratories Inc. July 2001 - June 2002
San Francisco State University September 1998 - July 2001
Skills
bioanalytical method..., protein characterization, PK/PD method..., HPLC/UPLC, LC/MS/MS
Education
Tsinghua University 1995 — 1998
PhD, Chemistry
Central China Normal University
MS, Chemistry
Central China Normal University
BS, Chemistry
William O'Dwyer's Gryphon Therapeutics Experience October 2001 - March 2004
Job Scientist at Genentech Inc.
Industry Biotechnology
Experience
Genentech Inc. October 2014 - Present
Genentech Inc. October 2012 - October 2014
Genentech Inc. October 2006 - October 2012
Genentech Inc. April 2004 - October 2006
Gryphon Therapeutics October 2001 - March 2004
Genentech June 1997 - April 2001
Skills
Biotechnology, Protein Purification, Purification, Chromatography, GMP, GLP, HPLC, Assay Development, Biopharmaceuticals
Education
University College Dublin 1989 — 1994
Bachelor's degree, Chemistry, BSc (Honours) Chemistry
Genentech Inc. October 2014 - Present
Genentech Inc. October 2012 - October 2014
Genentech Inc. October 2006 - October 2012
Genentech Inc. April 2004 - October 2006
Gryphon Therapeutics October 2001 - March 2004
Genentech June 1997 - April 2001
Skills
Biotechnology, Protein Purification, Purification, Chromatography, GMP, GLP, HPLC, Assay Development, Biopharmaceuticals
Education
University College Dublin 1989 — 1994
Bachelor's degree, Chemistry, BSc (Honours) Chemistry